MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective
The DOI matches its Crossref record; 229 of the 231 references it cites were found in a registry or an index.
Abstract
Despite dopamine-glutamate aberrant interaction that has long been considered a relevant landmark of psychosis pathophysiology, several aspects of these two neurotransmitters reciprocal interaction remain to be defined. The emerging role of postsynaptic density (PSD) proteins at glutamate synapse as a molecular "lego" making a functional hub where different signals converge may add a new piece of information to understand how dopamine-glutamate interaction may work with regard to schizophrenia pathophysiology and treatment. More recently, compelling evidence suggests a relevant role for microRNA (miRNA) as a new class of dopamine and glutamate modulators with regulatory functions in the reciprocal interaction of these two neurotransmitters. Here, we aimed at addressing the following issues: (i) Do miRNAs have a role in schizophrenia pathophysiology in the context of dopamine-glutamate aberrant interaction? (ii) If miRNAs are relevant for dopamine-glutamate interaction, at what level this modulation takes place? (iii) Finally, will this knowledge open the door to innovative diagnostic and therapeutic tools? The biogenesis of miRNAs and their role in synaptic plasticity with relevance to schizophrenia will be considered in the context of dopamine-glutamate interaction, with special focus on miRNA interaction with PSD elements. From this framework, implications both for biomarkers identification and potential innovative interventions will be considered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the glutamate is a major tonic/phasic release regulator or serotonin, dopamine, and norepinephrine, meaning that the phenomenon of pharmacodynamic tolerance takes more than a handful of monoamine, and/or multiple sites, timing and regulators [42].”
Citations
Cites
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
The nuclear RNase III Drosha initiates microRNA processing
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., et al. (2003) · Nature · doi:10.1038/nature01957 · Cited by 5,114
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation
Vasudevan, S., Tong, Y., & Steitz, J. A. (2007) · Science · doi:10.1126/science.1149460 · Cited by 2,822
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 2,060
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs
Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., & Tuschl, T. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.007 · Cited by 2,052
Burnside, R. D. (2015) · Cytogenetic and Genome Research · doi:10.1159/000438708 · Cited by 1,946
Genome-wide association study identifies five new schizophrenia loci
The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) · Nature Genetics · doi:10.1038/ng.940 · Cited by 1,919
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589
Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., & Ambros, V. (2004) · Genome Biology · doi:10.1186/gb-2004-5-3-r13 · Cited by 1,578
PDZ domain proteins of synapses
Kim, E., & Sheng, M. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1517 · Cited by 1,577
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Distinct Roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA Silencing Pathways
Lee, Y. S., Nakahara, K., Pham, J. W., Kim, K., He, Z., Sontheimer, E. J., & Carthew, R. W. (2004) · Cell · doi:10.1016/s0092-8674(04)00261-2 · Cited by 1,282
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
Coupling of mGluR/Homer and PSD-95 Complexes by the Shank Family of Postsynaptic Density Proteins
Tu, J. C., Xiao, B., Naisbitt, S., Yuan, J. P., Petralia, R. S., Brakeman, P., Doan, A., Aakalu, V. K., Lanahan, A. A., Sheng, M., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80810-7 · Cited by 1,050
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
High rates of schizophrenia in adults with velo-cardio-facial syndrome
Murphy, K. C., Jones, L. A., & Owen, M. J. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.940 · Cited by 1,024
NMDA receptor hypofunction model of schizophrenia
Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
Vijayraghavan, S., Wang, M., Birnbaum, S. G., Williams, G. V., & Arnsten, A. F. T. (2007) · Nature Neuroscience · doi:10.1038/nn1846 · Cited by 1,013
The Postsynaptic Architecture of Excitatory Synapses: A More Quantitative View
Sheng, M., & Hoogenraad, C. C. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060805.160029 · Cited by 1,003
miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche
Cheng, L.-C., Pastrana, E., Tavazoie, M., & Doetsch, F. (2009) · Nature Neuroscience · doi:10.1038/nn.2294 · Cited by 1,001
Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome
Abelson, J. F., Kwan, K. Y., O'Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M., Mathews, C. A., Pauls, D. L., Rašin, M.-R., Gunel, M., et al. (2005) · Science · doi:10.1126/science.1116502 · Cited by 940
Dopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880
Kirov, G., Pocklington, A. J., Holmans, P., Ivanov, D., Ikeda, M., Ruderfer, D., Moran, J., Chambert, K., Toncheva, D., Georgieva, L., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.154 · Cited by 844
Strong association of de novo copy number mutations with sporadic schizophrenia
Xu, B., Roos, J. L., Levy, S., van Rensburg, E. J., Gogos, J. A., & Karayiorgou, M. (2008) · Nature Genetics · doi:10.1038/ng.162 · Cited by 813
Reciprocal actions of REST and a microRNA promote neuronal identity
Conaco, C., Otto, S., Han, J.-J., & Mandel, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511041103 · Cited by 736
Regulation of Synaptic Structure and Function by FMRP-Associated MicroRNAs miR-125b and miR-132
Edbauer, D., Neilson, J. R., Foster, K. A., Wang, C.-F., Seeburg, D. P., Batterton, M. N., Tada, T., Dolan, B. M., Sharp, P. A., & Sheng, M. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.005 · Cited by 735
Prefrontal Dopamine D1Receptors and Working Memory in Schizophrenia
Abi-Dargham, A., Mawlawi, O., Lombardo, I., Gil, R., Martinez, D., Huang, Y., Hwang, D.-R., Keilp, J., Kochan, L., Van Heertum, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03708.2002 · Cited by 724
Specific microRNAs modulate embryonic stem cell-derived neurogenesis.
Krichevsky, A. M., Sonntag, K.-C., Isacson, O., & Kosik, K. S. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0441 · Cited by 692
The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development
Visvanathan, J., Lee, S., Lee, B., Lee, J. W., & Lee, S.-K. (2007) · Genes & Development · doi:10.1101/gad.1519107 · Cited by 683
Malhotra, M. D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00036-5 · Cited by 680
Fragile X-related protein and VIG associate with the RNA interference machinery
Caudy, A. A., Myers, M., Hannon, G. J., & Hammond, S. M. (2002) · Genes & Development · doi:10.1101/gad.1025202 · Cited by 655
Sawaguchi, T., & Goldman-Rakic, P. S. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.71.2.515 · Cited by 649
Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model
Stark, K. L., Xu, B., Bagchi, A., Lai, W.-S., Liu, H., Hsu, R., Wan, X., Pavlidis, P., Mills, A. A., Karayiorgou, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.138 · Cited by 648
Silencing of microRNA families by seed-targeting tiny LNAs
Obad, S., dos Santos, C. O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., Fu, C., Lindow, M., Stenvang, J., Straarup, E. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.786 · Cited by 627
Perkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., Parker, J. S., Jin, J., & Hammond, S. M. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r27 · Cited by 574
Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
Identification of many microRNAs that copurify with polyribosomes in mammalian neurons
Kim, J., Krichevsky, A., Grad, Y., Hayes, G. D., Kosik, K. S., Church, G. M., & Ruvkun, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2333854100 · Cited by 569
An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP
Wayman, G. A., Davare, M., Ando, H., Fortin, D., Varlamova, O., Cheng, H.-Y. M., Marks, D., Obrietan, K., Soderling, T. R., Goodman, R. H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803072105 · Cited by 559
Siegel, G., Obernosterer, G., Fiore, R., Oehmen, M., Bicker, S., Christensen, M., Khudayberdiev, S., Leuschner, P. F., Busch, C. J. L., Kane, C., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1876 · Cited by 500
From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome
Bagni, C., & Greenough, W. T. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1667 · Cited by 475
Conditional Loss of Dicer Disrupts Cellular and Tissue Morphogenesis in the Cortex and Hippocampus
Davis, T. H., Cuellar, T. L., Koch, S. M., Barker, A. J., Harfe, B. D., McManus, M. T., & Ullian, E. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4815-07.2008 · Cited by 447
Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437
Ketamine activates psychosis and alters limbic blood flow in schizophrenia
Lahti, A. C., Holcomb, H. H., Medoff, D. R., & Tamminga, C. A. (1995) · NeuroReport · doi:10.1097/00001756-199504190-00011 · Cited by 434
Schizophrenia is associated with an increase in cortical microRNA biogenesis
Beveridge, N. J., Gardiner, E., Carroll, A. P., Tooney, P. A., & Cairns, M. J. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.84 · Cited by 432
Lorrain, D. S., Baccei, C. S., Bristow, L. J., Anderson, J. J., & Varney, M. A. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00652-8 · Cited by 432
MicroRNA miR-137 Regulates Neuronal Maturation by Targeting Ubiquitin Ligase Mind Bomb-1
Smrt, R. D., Szulwach, K. E., Pfeiffer, R. L., Li, X., Guo, W., Pathania, M., Teng, Z.-Q., Luo, Y., Peng, J., Bordey, A., et al. (2010) · Stem Cells · doi:10.1002/stem.431 · Cited by 404
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.805 · Cited by 392
Striatal microRNA controls cocaine intake through CREB signalling
Hollander, J. A., Im, H.-I., Amelio, A. L., Kocerha, J., Bali, P., Lu, Q., Willoughby, D., Wahlestedt, C., Conkright, M. D., & Kenny, P. J. (2010) · Nature · doi:10.1038/nature09202 · Cited by 388
NONCODING RNAS IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM
Cao, X., Yeo, G., Muotri, A. R., Kuwabara, T., & Gage, F. H. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112839 · Cited by 379
Dunah, A. W., & Standaert, D. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05546.2001 · Cited by 373
Muddashetty, R. S., Nalavadi, V. C., Gross, C., Yao, X., Xing, L., Laur, O., Warren, S. T., & Bassell, G. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.006 · Cited by 364
Barbee, S. A., Estes, P. S., Cziko, A.-M., Hillebrand, J., Luedeman, R. A., Coller, J. M., Johnson, N., Howlett, I. C., Geng, C., Ueda, R., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.028 · Cited by 359
Treatment-Resistant Schizophrenia
Elkis, H. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.04.001 · Cited by 338
Dysregulation of miRNA 181b in the temporal cortex in schizophrenia
Beveridge, N. J., Tooney, P. A., Carroll, A. P., Gardiner, E., Bowden, N., Scott, R. J., Tran, N., Dedova, I., & Cairns, M. J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn005 · Cited by 328
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients
Hietala, J., Syvälahti, E., Kuoppamäki, M., Hietala, J., Syvälahti, E., Haaparanta, M., Kuoppamäki, M., Ruotsalainen, U., Vuorio, K., Räkköläinen, V., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91801-9 · Cited by 321
Krystal, J. H., Perry, E. B., Gueorguieva, R., Belger, A., Madonick, S. H., Abi-Dargham, A., Cooper, T. B., MacDougall, L., Abi-Saab, W., & D’Souza, D. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.985 · Cited by 317
Zhou, R., Yuan, P., Wang, Y., Hunsberger, J. G., Elkahloun, A., Wei, Y., Damschroder-Williams, P., Du, J., Chen, G., & Manji, H. K. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.131 · Cited by 316
Miller, B. H., Zeier, Z., Xi, L., Lanz, T. A., Deng, S., Strathmann, J., Willoughby, D., Kenny, P. J., Elsworth, J. D., Lawrence, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113793109 · Cited by 309
MicroRNA Loss Enhances Learning and Memory in Mice
Konopka, W., Kiryk, A., Novak, M., Herwerth, M., Parkitna, J. R., Wawrzyniak, M., Kowarsch, A., Michaluk, P., Dzwonek, J., Arnsperger, T., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3030-10.2010 · Cited by 306
Kim, A. H., Reimers, M., Maher, B., Williamson, V., McMichael, O., McClay, J. L., van den Oord, E. J. C. G., Riley, B. P., Kendler, K. S., & Vladimirov, V. I. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.002 · Cited by 298
CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking
Anderson, S. M., Famous, K. R., Sadri-Vakili, G., Kumaresan, V., Schmidt, H. D., Bass, C. E., Terwilliger, E. F., Cha, J.-H. J., & Pierce, R. C. (2008) · Nature Neuroscience · doi:10.1038/nn2054 · Cited by 295
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction
Kocerha, J., Faghihi, M. A., Lopez-Toledano, M. A., Huang, J., Ramsey, A. J., Caron, M. G., Sales, N., Willoughby, D., Elmen, J., Hansen, H. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805854106 · Cited by 295
Characterization of DGCR8/Pasha, the essential cofactor for Drosha in primary miRNA processing
Yeom, K.-H., Lee, Y., Han, J., Suh, M. R., & Kim, V. N. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl458 · Cited by 290
Lindström, L. H., Gefvert, O., Hagberg, G., Lundberg, T., Bergström, M., Hartvig, P., & Långström, B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00109-2 · Cited by 284
MicroRNA-223 is neuroprotective by targeting glutamate receptors
Harraz, M. M., Eacker, S. M., Wang, X., Dawson, T. M., & Dawson, V. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121288109 · Cited by 283
Moreau, M. P., Bruse, S. E., David-Rus, R., Buyske, S., & Brzustowicz, L. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.039 · Cited by 279
microRNAs miR-124, let-7d and miR-181a regulate Cocaine-induced Plasticity
Chandrasekar, V., & Dreyer, J.-L. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.08.009 · Cited by 279
Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia
Abi-Dargham, A., & Moore, H. (2003) · The Neuroscientist · doi:10.1177/1073858403252674 · Cited by 277
Heterogeneous dysregulation of microRNAs across the autism spectrum
Abu-Elneel, K., Liu, T., Gazzaniga, F. S., Nishimura, Y., Wall, D. P., Geschwind, D. H., Lao, K., & Kosik, K. S. (2008) · neurogenetics · doi:10.1007/s10048-008-0133-5 · Cited by 271
Regulation of Akt Signaling by D2and D3Dopamine Receptors In Vivo
Beaulieu, J.-M., Tirotta, E., Sotnikova, T. D., Masri, B., Salahpour, A., Gainetdinov, R. R., Borrelli, E., & Caron, M. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5074-06.2007 · Cited by 269
Liu, X., Zhan, Z., Xu, L., Ma, F., Li, D., Guo, Z., Li, N., & Cao, X. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001573 · Cited by 269
Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain
Lugli, G., Torvik, V. I., Larson, J., & Smalheiser, N. R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05413.x · Cited by 268
Banigan, M. G., Kao, P. F., Kozubek, J. A., Winslow, A. R., Medina, J., Costa, J., Schmitt, A., Schneider, A., Cabral, H., Cagsal-Getkin, O., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0048814 · Cited by 266
Lugli, G., Larson, J., Martone, M. E., Jones, Y., & Smalheiser, N. R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03224.x · Cited by 263
Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion
Mukai, J., Dhilla, A., Drew, L. J., Stark, K. L., Cao, L., MacDermott, A. B., Karayiorgou, M., & Gogos, J. A. (2008) · Nature Neuroscience · doi:10.1038/nn.2204 · Cited by 260
Brain Expressed microRNAs Implicated in Schizophrenia Etiology
Hansen, T., Olsen, L., Lindow, M., Jakobsen, K. D., Ullum, H., Jonsson, E., Andreassen, O. A., Djurovic, S., Melle, I., Agartz, I., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000873 · Cited by 259
Huang, B., Zhao, J., Lei, Z., Shen, S., Li, D., Shen, G., Zhang, G., & Feng, Z. (2009) · EMBO reports · doi:10.1038/embor.2008.224 · Cited by 256
Santarelli, D. M., Beveridge, N. J., Tooney, P. A., & Cairns, M. J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.030 · Cited by 254
Boeckers, T. M. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0274-5 · Cited by 240
Hwang, D. W., Son, S., Jang, J., Youn, H., Lee, S., Lee, D., Lee, Y.-S., Jeong, J. M., Kim, W. J., & Lee, D. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.047 · Cited by 234
Feyder, M., Karlsson, R.-M., Mathur, P., Lyman, M., Bock, R., Momenan, R., Munasinghe, J., Scattoni, M. L., Ihne, J., Camp, M., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10040484 · Cited by 233
Gardiner, E., Beveridge, N. J., Wu, J. Q., Carr, V, Scott, R. J., Tooney, P. A., & Cairns, M. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.78 · Cited by 231
MicroRNA Expression Aberration as Potential Peripheral Blood Biomarkers for Schizophrenia
Lai, C.-Y., Yu, S.-L., Hsieh, M. H., Chen, C.-H., Chen, H.-Y., Wen, C.-C., Huang, Y.-H., Hsiao, P.-C., Hsiao, C. K., Liu, C.-M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021635 · Cited by 228
Sarachana, T., Zhou, R., Chen, G., Manji, H. K., & Hu, V. W. (2010) · Genome Medicine · doi:10.1186/gm144 · Cited by 228
Synapse- and Stimulus-Specific Local Translation During Long-Term Neuronal Plasticity
Wang, D. O., Kim, S. M., Zhao, Y., Hwang, H., Miura, S. K., Sossin, W. S., & Martin, K. C. (2009) · Science · doi:10.1126/science.1173205 · Cited by 226
Hallett, P. J., Spoelgen, R., Hyman, B. T., Standaert, D. G., & Dunah, A. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0792-06.2006 · Cited by 225
Cuellar, T. L., Davis, T. H., Nelson, P. T., Loeb, G. B., Harfe, B. D., Ullian, E., & McManus, M. T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801689105 · Cited by 222
Kristiansen, L. V., Beneyto, M., Haroutunian, V, & Meador-Woodruff, J. H. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001844 · Cited by 220
Dopamine-Regulated MicroRNA MiR-181a Controls GluA2 Surface Expression in Hippocampal Neurons
Saba, R., Störchel, P. H., Aksoy-Aksel, A., Kepura, F., Lippi, G., Plant, T. D., & Schratt, G. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05896-11 · Cited by 219
Transcriptome-wide Discovery of microRNA Binding Sites in Human Brain
Boudreau, R. L., Jiang, P., Gilmore, B. L., Spengler, R. M., Tirabassi, R., Nelson, J. A., Ross, C. A., Xing, Y., & Davidson, B. L. (2014) · Neuron · doi:10.1016/j.neuron.2013.10.062 · Cited by 217
Dicer ablation in oligodendrocytes provokes neuronal impairment in mice
Shin, D., Shin, J., McManus, M. T., Ptáček, L. J., & Fu, Y. (2009) · Annals of Neurology · doi:10.1002/ana.21927 · Cited by 208
Rethinking schizophrenia in the context of normal neurodevelopment
Catts, V. S., Fung, S. J., Long, L. E., Joshi, D., Vercammen, A., Allen, K. M., Fillman, S. G., Rothmond, D. A., Sinclair, D., Tiwari, Y., et al. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00060 · Cited by 206
MicroRNA regulation of homeostatic synaptic plasticity
Cohen, J. E., Lee, P. R., Chen, S., Li, W., & Fields, R. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017576108 · Cited by 202
Evolutionary expansion and anatomical specialization of synapse proteome complexity
Emes, R. D., Pocklington, A. J., Anderson, C. N. G., Bayes, A., Collins, M. O., Vickers, C. A., Croning, M. D. R., Malik, B. R., Choudhary, J. S., Armstrong, J. D., et al. (2008) · Nature Neuroscience · doi:10.1038/nn.2135 · Cited by 196
Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Kraguljac, N. V., White, D. M., Reid, M. A., & Lahti, A. C. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2437 · Cited by 191
Regulation of Opioid Tolerance by let-7 Family MicroRNA Targeting the μ Opioid Receptor
He, Y., Yang, C., Kirkmire, C. M., & Wang, Z. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2419-10.2010 · Cited by 186
López-Gil, X., Babot, Z., Amargós-Bosch, M., Suñol, C., Artigas, F., & Adell, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301356 · Cited by 183
Clinton, S. M., & Meador-Woodruff, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300451 · Cited by 176
Kawashima, H., Numakawa, T., Kumamaru, E., Adachi, N., Mizuno, H., Ninomiya, M., Kunugi, H., & Hashido, K. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.057 · Cited by 172
Stress-induced Reversal of MicroRNA Repression and mRNA P-body Localization in Human Cells
BHATTACHARYYA, S. N., HABERMACHER, R., MARTINE, U., CLOSS, E. I., & FILIPOWICZ, W. (2006) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2006.71.038 · Cited by 170
Green, M. J., Cairns, M. J., Wu, J. Q., Dragović, M., Jablensky, A. V., Tooney, P. A., Scott, R. J., & Carr, V. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.84 · Cited by 166
Deletion of Astroglial Dicer Causes Non-Cell-Autonomous Neuronal Dysfunction and Degeneration
Tao, J., Wu, H., Lin, Q., Wei, W., Lu, X.-H., Cantle, J. P., Ao, Y., Olsen, R. W., Yang, X. W., Mody, I., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0567-11.2011 · Cited by 166
Multifunctional Iron Oxide Nanoparticles for Diagnostics, Therapy and Macromolecule Delivery
Yen, S. K., Padmanabhan, P., & Selvan, S. T. (2013) · Theranostics · doi:10.7150/thno.4827 · Cited by 166
Talebizadeh, Z., Butler, M. G., & Theodoro, M. F. (2008) · Autism Research · doi:10.1002/aur.33 · Cited by 157
Dutta, R., Chomyk, A. M., Chang, A., Ribaudo, M. V., Deckard, S. A., Doud, M. K., Edberg, D. D., Bai, B., Li, M., Baranzini, S. E., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23860 · Cited by 155
Aberrant expression of serum miRNAs in schizophrenia
Shi, W., Du, J., Qi, Y., Liang, G., Wang, T., Li, S., Xie, S., Zeshan, B., & Xiao, Z. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.010 · Cited by 154
Non‐coding RNAs in the nervous system
Mehler, M. F., & Mattick, J. S. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.113191 · Cited by 154
DARPP-32 Is a Robust Integrator of Dopamine and Glutamate Signals
Fernandez, É., Schiappa, R., Girault, J.-A., & Novère, N. L. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020176 · Cited by 153
Xu, B., Hsu, P.-K., Stark, K. L., Karayiorgou, M., & Gogos, J. A. (2013) · Cell · doi:10.1016/j.cell.2012.11.052 · Cited by 145
Wibrand, K., Panja, D., Tiron, A., Ofte, M. L., Skaftnesmo, K., Lee, C. S., Pena, J. T. G., Tuschl, T., & Bramham, C. R. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07112.x · Cited by 140
Yang, L., Mao, L., Tang, Q., Samdani, S., Liu, Z., & Wang, J. Q. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2496-04.2004 · Cited by 138
de Bartolomeis, A., Latte, G., Tomasetti, C., & Iasevoli, F. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8534-3 · Cited by 137
Self-citationAnalysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex
Guella, I., Sequeira, A., Rollins, B., Morgan, L., Torri, F., van Erp, T. G. M., Myers, R. M., Barchas, J. D., Schatzberg, A. F., Watson, S. J., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.021 · Cited by 134
D‐Aspartic acid is a novel endogenous neurotransmitter
D'Aniello, S., Somorjai, I., Garcia‐Fernàndez, J., Topo, E., & D'Aniello, A. (2011) · The FASEB Journal · doi:10.1096/fj.10-168492 · Cited by 131
Lett, T. A. P., Chakavarty, M. M., Felsky, D., Brandl, E. J., Tiwari, A. K., Gonçalves, V. F., Rajji, T. K., Daskalakis, Z. J., Meltzer, H. Y., Lieberman, J. A., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.17 · Cited by 129
Errico, F., Rossi, S., Napolitano, F., Catuogno, V., Topo, E., Fisone, G., D’Aniello, A., Centonze, D., & Usiello, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1618-08.2008 · Cited by 129
PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking
Porras, G., Berthet, A., Dehay, B., Li, Q., Ladepeche, L., Normand, E., Dovero, S., Martinez, A., Doudnikoff, E., Martin-Négrier, M.-L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59426 · Cited by 129
Neurotransmitters Drive Combinatorial Multistate Postsynaptic Density Networks
Coba, M. P., Pocklington, A. J., Collins, M. O., Kopanitsa, M. V., Uren, R. T., Swamy, S., Croning, M. D. R., Choudhary, J. S., & Grant, S. G. N. (2009) · Science Signaling · doi:10.1126/scisignal.2000102 · Cited by 129
Age-Dependent MicroRNA Control of Synaptic Plasticity in 22q11 Deletion Syndrome and Schizophrenia
Earls, L. R., Fricke, R. G., Yu, J., Berry, R. B., Baldwin, L. T., & Zakharenko, S. S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1312-12.2012 · Cited by 127
Maffioletti, E., Tardito, D., Gennarelli, M., & Bocchio-Chiavetto, L. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00075 · Cited by 121
Differential Allelic Expression of Dopamine D1 Receptor Gene (DRD1) Is Modulated by microRNA miR-504
Huang, W., & Li, M. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.024 · Cited by 121
Potential Impact of miR-137 and Its Targets in Schizophrenia
Wright, C., Turner, J. A., Calhoun, V. D., & Perrone-Bizzozero, N. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00058 · Cited by 120
Clinton, S. M., Haroutunian, V., Davis, K. L., & Meador-Woodruff, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.6.1100 · Cited by 119
Lindsay, E. A., Greenberg, F., Shaffer, L. G., Shapira, S. K., Scambler, P. J., & Baldini, A. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560216 · Cited by 118
Distinct Roles for Different Homer1 Isoforms in Behaviors and Associated Prefrontal Cortex Function
Lominac, K. D., Oleson, E. B., Pava, M., Klugmann, M., Schwarz, M. K., Seeburg, P. H., During, M. J., Worley, P. F., Kalivas, P. W., & Szumlinski, K. K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3764-05.2005 · Cited by 118
Ghasemzadeh, M. B., Mueller, C., & Vasudevan, P. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.027 · Cited by 115
A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene
Zhu, Y., Kalbfleisch, T., Brennan, M. D., & Li, Y. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.01.022 · Cited by 113
Errico, F., Napolitano, F., Squillace, M., Vitucci, D., Blasi, G., de Bartolomeis, A., Bertolino, A., D’Aniello, A., & Usiello, A. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.06.013 · Cited by 112
Abnormal Cortical Growth in Schizophrenia Targets Normative Modules of Synchronized Development
Alexander-Bloch, A. F., Reiss, P. T., Rapoport, J., McAdams, H., Giedd, J. N., Bullmore, E. T., & Gogtay, N. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.02.010 · Cited by 110
Tsukada, H., Nishiyama, S., Fukumoto, D., Sato, K., Kakiuchi, T., & Domino, E. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300732 · Cited by 109
MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia
Xu, Y. J., Li, F., Zhang, B., Zhang, K., Zhang, F., Huang, X., Sun, N., Ren, Y., Sui, M., & Liu, P. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1070 · Cited by 105
Iasevoli, F., Tomasetti, C., & de Bartolomeis, A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0886-y · Cited by 105
Self-citationWeston–Green, K., Huang, X., & Deng, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033548 · Cited by 104
MicroRNA in schizophrenia: Genetic and expression analysis of miR-130b (22q11)
Burmistrova, O. A., Goltsov, A. Y., Abramova, L. I., Kaleda, V. G., Orlova, V. A., & Rogaev, E. I. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907050161 · Cited by 101
Polymer Nanoparticle-Mediated Delivery of MicroRNA Inhibition and Alternative Splicing
Cheng, C. J., & Saltzman, W. M. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300081s · Cited by 98
Evidence for X-Chromosomal Schizophrenia Associated with microRNA Alterations
Feng, J., Sun, G., Yan, J., Noltner, K., Li, W., Buzin, C. H., Longmate, J., Heston, L. L., Rossi, J., & Sommer, S. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006121 · Cited by 95
The road toward microRNA therapeutics
Seto, A. G. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.03.003 · Cited by 95
New insights on the role of free d-aspartate in the mammalian brain
Errico, F., Napolitano, F., Nisticò, R., & Usiello, A. (2012) · Amino Acids · doi:10.1007/s00726-012-1356-1 · Cited by 94
Schizophrenia as a Disorder of Molecular Pathways
Horváth, S., & Mirnics, K. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.001 · Cited by 91
Kocerha, J., Kauppinen, S., & Wahlestedt, C. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8066-1 · Cited by 91
Whalley, H. C., Papmeyer, M., Romaniuk, L., Sprooten, E., Johnstone, E. C., Hall, J., Lawrie, S. M., Evans, K. L., Blumberg, H. P., Sussmann, J. E., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.137 · Cited by 89
de Bartolomeis, A., Buonaguro, E. F., & Iasevoli, F. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2921-8 · Cited by 89
Self-citationMicroRNA Conjugated Gold Nanoparticles and Cell Transfection
Crew, E., Rahman, S., Razzak-Jaffar, A., Mott, D. M., Kamundi, M., Yu, G., Tchah, N., Lee, J., Bellavia, M. C., & Zhong, C. (2011) · Analytical Chemistry · doi:10.1021/ac202749p · Cited by 89
Bartolomeis, A. D., MD, PhD, Iasevoli, A. F., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4173 · Cited by 88
Didriksen, M., Skarsfeldt, T., & Arnt, J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0774-3 · Cited by 85
Antipsychotic drug actions on gene modulation and signaling mechanisms
Molteni, R., Calabrese, F., Racagni, G., Fumagalli, F., & Riva, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.001 · Cited by 85
Delint-Ramirez, I., Fernandez, E., Bayes, A., Kicsi, E., Komiyama, N. H., & Grant, S. G. N. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1792-10.2010 · Cited by 84
Regional Decoupling of N-acetyl-aspartate and Glutamate in Schizophrenia
Kraguljac, N. V., Reid, M. A., White, D. M., den Hollander, J., & Lahti, A. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.126 · Cited by 84
PSD-95 Uncouples Dopamine–Glutamate Interaction in the D1/PSD-95/NMDA Receptor Complex
Zhang, J., Xu, T.-X., Hallett, P. J., Watanabe, M., Grant, S. G. N., Isacson, O., & Yao, W.-D. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4424-08.2009 · Cited by 82
Earls, L. R., Bayazitov, I. T., Fricke, R. G., Berry, R. B., Illingworth, E., Mittleman, G., & Zakharenko, S. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1425-10.2010 · Cited by 79
de Bartolomeis, A., Sarappa, C., Magara, S., & Iasevoli, F. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.02.033 · Cited by 79
Self-citationMicroRNAs -the Next Generation Therapeutic Targets in Human Diseases
Sakthivel, S., Selvan, S. T., Archunan, G., Gulyás, B. Z., & Padmanabhan, P. (2013) · Theranostics · doi:10.7150/thno.7026 · Cited by 79
Jentsch, J. D., Elsworth, J. D., Redmond Jr., D. E., & Roth, R. H. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01769.1997 · Cited by 77
Cummings, E., Donohoe, G. J., Hargreaves, A., Moore, S., Fahey, C., Dinan, T. G., McDonald, C., O’Callaghan, E., O’Neill, F. A., Waddington, J. L., et al. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.08.065 · Cited by 77
MicroRNAs in Neuronal Communication
Higa, G. S. V., de Sousa, É., Walter, L. T., Kinjo, É. R., Resende, R. R., & Kihara, A. H. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8603-7 · Cited by 75
Complex, multimodal behavioral profile of the Homer1 knockout mouse
Jaubert, P. J., Golub, M. S., Lo, Y. Y., Germann, S. L., Dehoff, M. H., Worley, P. F., Kang, S. H., Schwarz, M. K., Seeburg, P. H., & Berman, R. F. (2007) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2006.00240.x · Cited by 75
Gender-Specific Reduction of Estrogen-Sensitive Small RNA, miR-30b, in Subjects With Schizophrenia
Mellios, N., Galdzicka, M., Ginns, E., Baker, S. P., Rogaev, E., Xu, J., & Akbarian, S. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq091 · Cited by 75
de Bartolomeis, A., Sarappa, C., Buonaguro, E. F., Marmo, F., Eramo, A., Tomasetti, C., & Iasevoli, F. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.010 · Cited by 72
Self-citationIn Vivo Regulation of Homer1a Expression in the Striatum by Cocaine
Zhang, G.-C., Mao, L., Liu, X., Parelkar, N. K., Arora, A. K., Yang, L., Hains, M., Fibuch, E. E., & Wang, J. Q. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.028399 · Cited by 71
In Vivo MicroRNA Detection and Quantitation in Cerebrospinal Fluid
Gallego, J. A., Gordon, M. L., Claycomb, K., Bhatt, M., Lencz, T., & Malhotra, A. K. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9731-7 · Cited by 69
McKibben, C. E., Jenkins, T. A., Adams, H. N., Harte, M., & Reynolds, G. P. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.11.018 · Cited by 68
Shi, S., Zhong, Z., Liu, J., Zhang, Z., Sun, X., & Gong, T. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0514-6 · Cited by 68
Fasano, C., Bourque, M.-J., Lapointe, G., Leo, D., Thibault, D., Haber, M., Kortleven, C., DesGroseillers, L., Murai, K. K., & Trudeau, L.-É. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.030 · Cited by 67
Spellmann, I., Rujescu, D., Musil, R., Mayr, A. J., Giegling, I., Genius, J., Zill, P., Dehning, S., Opgen-Rhein, M., Cerovecki, A., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.06.004 · Cited by 67
Sarantis, K., Matsokis, N. A., & Angelatou, F. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.056 · Cited by 66
de Bartolomeis, A., & Tomasetti, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8293-6 · Cited by 65
Self-citationMicroRNA-206: a Promising Theranostic Marker
Novák, J., Kružliak, P., Vašků, J. B., Slabý, O., & Novák, M. (2014) · Theranostics · doi:10.7150/thno.7552 · Cited by 64
Clinton, S. M., Haroutunian, V., & Meador‐Woodruff, J. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03954.x · Cited by 64
Hill, M. J., Donocik, J. G., Nuamah, R. A., Mein, C. A., Sainz-Fuertes, R., & Bray, N. J. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.034 · Cited by 64
Mutation screening of the Homer gene family and association analysis in schizophrenia
Norton, N., Williams, H. J., Williams, N. M., Spurlock, G., Zammit, S., Jones, G., Jones, S., Owen, R., O'Donovan, M. C., & Owen, M. J. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20032 · Cited by 61
Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex
Kruse, M. S., Prémont, J., Krebs, M.-O., & Jay, T. M. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.12.006 · Cited by 60
Cheng, M.-C., Lu, C.-L., Luu, S.-U., Tsai, H.-M., Hsu, S.-H., Chen, T.-T., & Chen, C.-H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015107 · Cited by 59
Iasevoli, F., Tomasetti, C., Buonaguro, E. F., & de Bartolomeis, A. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140324183406 · Cited by 58
Self-citationHenriksen, M., Johnsen, K. B., Andersen, H. H., Pilgaard, L., & Duroux, M. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8668-y · Cited by 55
Berger, F., & Reiser, M. F. (2013) · Theranostics · doi:10.7150/thno.7445 · Cited by 55
Scott, L., & Aperia, A. C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.020 · Cited by 54
Iasevoli, F., Tomasetti, C., Marmo, F., Bravi, D., Arnt, J., & de Bartolomeis, A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1954-0 · Cited by 52
Self-citationSantarelli, D. M., Liu, B., Duncan, C. E., Beveridge, N. J., Tooney, P. A., Schofield, P. R., & Cairns, M. J. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2939-y · Cited by 51
Sarantis, K., Antoniou, K., Matsokis, N. A., & Angelatou, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.10.018 · Cited by 50
Tomasetti, C., Dell’Aversano, C., Iasevoli, F., & de Bartolomeis, A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.08.022 · Cited by 49
Self-citationMeisenzahl, E., Schmitt, G., Gründer, G., Dresel, S., Frodl, T., la Fougère, C., Scheuerecker, J., Schwarz, M., Boerner, R., Stauss, J., et al. (2008) · Pharmacopsychiatry · doi:10.1055/s-2008-1076727 · Cited by 49
Evaluation of Six SNPs of MicroRNA Machinery Genes and Risk of Schizophrenia
Zhou, Y., Wang, J., Lu, X., Song, X., Ye, Y., Zhou, J., Ying, B., & Wang, L. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9887-1 · Cited by 49
Iasevoli, F., Tomasetti, C., Ambesi‐Impiombato, A., Muscettola, G., & de Bartolomeis, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.02.009 · Cited by 49
Self-citationPerinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life
du Bois, T. M., Newell, K. A., & Huang, X. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.002 · Cited by 48
Park, S. W., Lee, C. H., Cho, H. Y., Seo, M. K., Lee, J. G., Lee, B. J., Seol, W., Kee, B. S., & Kim, Y. H. (2013) · Synapse · doi:10.1002/syn.21634 · Cited by 47
de Bartolomeis, A., & Fiore, G. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59009-8 · Cited by 47
Ladépêche, L., Yang, L., Bouchet, D., & Groc, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074512 · Cited by 46
The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3
Sutton, L. P., & Rushlow, W. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571100109x · Cited by 46
Therapeutic Advances in MicroRNA Targeting
Montgomery, R. L., & van Rooij, E. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181f603d0 · Cited by 44
Iasevoli, F., Ambesi-Impiombato, A., Fiore, G., Panariello, F., Muscettola, G., & de Bartolomeis, A. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109358199 · Cited by 44
Self-citationWong, J., Duncan, C. E., Beveridge, N. J., Webster, M. J., Cairns, M. J., & Shannon Weickert, C. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr177 · Cited by 43
Ghasemzadeh, M. B., Windham, L. K., Lake, R. W., Acker, C. J., & Kalivas, P. W. (2009) · Synapse · doi:10.1002/syn.20577 · Cited by 43
Iasevoli, F., Fiore, G., Cicale, M., Muscettola, G., & de Bartolomeis, A. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.02.009 · Cited by 42
Self-citationKneussel, M. (2005) · EMBO reports · doi:10.1038/sj.embor.7400319 · Cited by 41
miRNA regulons associated with synaptic function
Paschou, M., Paraskevopoulou, M. D., Vlachos, I. S., Koukouraki, P., Hatzigeorgiou, A. G., & Doxakis, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046189 · Cited by 41
Research works printed but not linked: 1
- de Bartolomeis A, Latte G, Tomasetti C, Iasevoli F (2014) Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches. Mol Neurobiol 49(1):484–511. doi: 10.1007/s12035-013-8534-3 · DOI
Cited by
de Bartolomeis, A., Barone, A., Vellucci, L., Mazza, B., Austin, M. C., Iasevoli, F., & Ciccarelli, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02976-3 · Cited by 113
Self-citationFornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80
Dysregulation of mi RNA and its potential therapeutic application in schizophrenia
Cao, T., & Zhen, X. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12840 · Cited by 77
Tomasetti, C., Iasevoli, F., Buonaguro, E., De Berardis, D., Fornaro, M., Fiengo, A., Martinotti, G., Orsolini, L., Valchera, A., Di Giannantonio, M., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010135 · Cited by 71
“Moreover, a crucial role of microRNAs interactions with PSD molecules has been suggested in the radical synaptic plasticity rearrangements induced by antipsychotics [66].”
BackgroundSelf-citationNarla, S. T., Lee, Y. W., Benson, C. A., Sarder, P., Brennand, K., Stachowiak, E. K., & Stachowiak, M. K. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.12.012 · Cited by 64
“Earlier studies have shown that somemiRNAs may be dysregulated in the brains of schizophrenia patients (de Bartolomeis et al., 2015; Hill et al., 2014).”
Background
Metadata
- Authors
- de Bartolomeis, A., Iasevoli, F., Tomasetti, C., & Buonaguro, E. F.
- Affiliations
- Federico II University Hospital (IT)
- Venue
- Molecular Neurobiology
- Published
- 2014-11-14
- Volume
- 52
- Issue
- 3
- Pages
- 1771-1790
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2062239841
- Cited by
- 21
- References
- 231
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 2 · 2019: 2 · 2018: 4 · 2017: 2 · 2016: 1 · 2015: 3
- FWCI
- 0.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microRNA, schizophrenia, dopamine-glutamate interaction, postsynaptic density, synaptic plasticity, microRNA biogenesis, antipsychotic drugs, theranostics, biomarkers, glutamatergic synapses
- MeSH terms
- Animals, Dopamine, Humans, Neuronal Plasticity, Schizophrenia, Antipsychotic Agents, Glutamic Acid, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.